A pilot study to investigate stakeholder views in pharmacogenetic testing as an aid to clinical decision making in treatment with clozapine in schizophrenia.
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Clozapine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 05 Aug 2013 Accrual to date is 100% according to United Kingdom Clinical Research Network record.
- 27 Jul 2013 Accrual to date is 25% according to United Kingdom Clinical Research Network record.
- 25 Jul 2013 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network.